Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by mr_man_0915on Jan 19, 2007 5:59pm
152 Views
Post# 12054517

RE: results from the first 3 holes

RE: results from the first 3 holesThis thing has also traded in unappealing ways since I've watched it. Mr. Drill; I'm curious, if one accepts the rough resource calculations you offered as a fair and reasonable interpetion of the results (not suggesting it isn't by the way) what is the likelyhood of a deposit of that size being developed? I find one of the tricker wickets to be moving my analysis of these things beyond whether a particular prospect has an economically viable business on its proven, inferred or even prospective resource base, in isolation....as opposed to their prospects in the real world of significant numbers of strategic competitors, many of which are chasing different sized pies... Seems to me, and I'm no expert yet, that a lot of uranium comes from big deposits and farily mega sized projects...if so, what is the likelyhood that...I don't know, pick a number...50 new uranium deposits are being mined 10 years from now...how many will be digging for deposits of this size?...uranium isn't rare, it's just hard to find good concentrated mineable grades...if elephant deposits are going to rule the next decade, then at what size does a play become a trunck wagging peanut eater versus a floppy eared weak-kneed Dumbo?
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse